Literature DB >> 6318500

Pituitary adenomas: immunohistology and ultrastructural analysis of 118 tumors.

M M Esiri, C B Adams, C Burke, R Underdown.   

Abstract

An analysis is presented of the immunohistological and ultrastructural features in a series of 118 surgically removed pituitary adenomas all of which were studied immunohistologically using antisera to growth hormone (GH), prolactin (PRL) ACTH, beta FSH, beta LH and beta TSH, and 75 of which were studied ultrastructurally. Results were analysed according to the mode of presentation of patients. Forty-one (35%) of the tumours were from patients with acromegaly or gigantism, ten (9%) from patients with Cushing's syndrome or Nelson's syndrome, 19 (16%) from patients with clinical features associated with hyperprolactinaemia and 48 (40%) from patients with space occupying lesions which appeared clinically to be overtly endocrinologically functionless. By light microscopy, using the immunoperoxidase (PAP) technique, immunoreactive GH was demonstrated in all the tumours from patients with acromegaly or gigantism, immunoreactive ACTH in all tumours from patients with Cushing's syndrome or Nelson's syndrome and immunoreactive PRL in 95% of tumours associated with effects of hyperprolactinaemia. Forty-five percent of the tumours from acromegalic patients contained some PRL-positive cells as well as GH-positive cells. Among the tumours which appeared clinically to be endocrinologically functionless were three tumours (from males) uniformly stained for immunoreactive PRL. Of the remainder, 60% were negative for immunoreactive hormones and 40% contained small numbers of cells which were positive for a variety of immunoreactive hormones. ACTH-cell and PRL-cell tumours had ultrastructural features as described in previous studies. Fifty percent of GH-cell tumours examined at the EM level contained fibrous bodies, while in the remainder these structures were not identified. Tumours with fibrous bodies were more likely to contain PRL as well as GH with immunoperoxidase. All tumours that were endocrinologically functionless and which were examined at the EM level contained secretory granules. Oncocytic change was common in these tumours. No ultrastructural differences were observed between those which contained immunoreactive hormones by light microscopy and those which did not.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318500     DOI: 10.1007/bf00684914

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  Massive Crooke's hyalinization in corticotroph cell adenomas of the human pituitary. A histological, immunocytological, and electron microscopic study of three cases.

Authors:  I A Felix; E Horvath; K Kovacs
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

2.  Corticolipotropin immunoreactivity in silent chromophobe adenomas: a light and electron microscopic study.

Authors:  J Hassoun; C Charpin; P Jaquet; J C Lissitzky; F Grisoli; M Toga
Journal:  Arch Pathol Lab Med       Date:  1982-01       Impact factor: 5.534

3.  Immunohistochemical and electron-microscopic studies of functional and non-functional pituitary adenomas including one TSH secreting tumor in a thyrotoxic patient.

Authors:  H Cravioto; T Fukaya; E A Zimmerman; D L Kleinberg; E S Flamm
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

4.  [Prolactinoma: pathologic aspects].

Authors:  F Robert
Journal:  Neurochirurgie       Date:  1981       Impact factor: 1.553

5.  Ultrastructural classification of pituitary adenomas.

Authors:  E Horvath; K Kovacs
Journal:  Can J Neurol Sci       Date:  1976-02       Impact factor: 2.104

6.  Localization of prolactin in chromophobe pituitary adenomas: study of human necropsy material by immunoperoxidase technique.

Authors:  K Kovacs; B Corenblum; A M Sirek; G Penz; C Ezrin
Journal:  J Clin Pathol       Date:  1976-03       Impact factor: 3.411

7.  Use of immunohistochemical and morphologic methods for the identification of human growth hormone-producing pituitary adenomas.

Authors:  A C Nieuwenhuyzen Kruseman; G T Bots; J Lindeman; A Schaberg
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

8.  Argyrophil pituitary tumors showing TSH cells or small granule cells.

Authors:  C Capella; L Usellini; B Frigerio; R Buffa; P Fontana; E Solcia
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-03-23

9.  Correlative ultrastructural morphometry of human prolactin-producing adenomas.

Authors:  D J McComb; K Kovacs; E Horvath; W Singer; D W Killinger; H S Smyth; C Ezrin; M H Weiss
Journal:  Acta Neurochir (Wien)       Date:  1980       Impact factor: 2.216

10.  Ultrastructure, immunohistochemistry and hormone release of pituitary adenomas in relation to prolactin production.

Authors:  T Kameya; M Tsumuraya; I Adachi; K Abe; K Ichikizaki; S Toya; R Demura
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980
View more
  9 in total

Review 1.  Human pituitary adenomas. Recent advances in morphological studies.

Authors:  G Giannattasio; M Bassetti
Journal:  J Endocrinol Invest       Date:  1990-05       Impact factor: 4.256

2.  Thyroid stimulating and gonadotrophic hormones in pituitary adenomas without clinical or serological abnormality.

Authors:  E Hitchcock; C S Morris
Journal:  Histochem J       Date:  1986-06

Review 3.  Medical therapy of gonadotropin-producing and nonfunctioning pituitary adenomas.

Authors:  Mansur E Shomali; Laurence Katznelson
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

4.  The management of pituitary tumours and post-operative visual deterioration.

Authors:  C B Adams
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

5.  Pituitary adenomas in patients under 20 years old. A clinicopathological study of 12 cases.

Authors:  K Mukai; E L Seljeskog; L P Dehner
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

6.  Pathological and experimental investigations in a case of gigantism.

Authors:  I Fazekas; E Pásztor; F Slowik; K Bálint; I Dobronyi; E Bácsy; A Gyévai; F Péter; L Blatniczky; I Varga
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

7.  Role of cell and explant culture in the diagnosis and characterization of human pituitary tumours.

Authors:  E F Adams; K Mashiter
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

8.  Pituitary adenomas in acromegaly: Comparison of different adenoma types with clinical data.

Authors:  D Voit; W Saeger; D K Lüdecke
Journal:  Endocr Pathol       Date:  1999-06       Impact factor: 3.943

9.  Pituitary incidentaloma: an endocrine society clinical practice guideline.

Authors:  Pamela U Freda; Albert M Beckers; Laurence Katznelson; Mark E Molitch; Victor M Montori; Kalmon D Post; Mary Lee Vance
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.